Additionally, PFKFB3 activation has been linked to the impairment of endothelial barrier function within the tumor microenvironment by promoting VE-cadherin endocytosis in endothelial cells and reducing the adhesive properties of pericytes through downregulating N-cadherin expression [31]. The gene discussed is CDH2; the disease is neoplasm.